Preservation of salivary gland function using low dose amifostine in thyroid cancer patients receiving radioiodine therapy

被引：0
|
作者：
Haindl, W
Frater, CJ
Taylor, JE
Rossleigh, MA
机构：
[1] Prince Wales Hosp, Dept Nucl Med, Sydney, NSW, Australia
[2] Nucl Diagnost Randwick, Sydney, NSW, Australia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [31] Quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer
    Abdulrezzak, Ummuhan
    Tutus, Ahmet
    Isik, Ilknur
    Kurt, Yurdagul
    Kula, Mustafa
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (03): : 314 - 322
  • [32] The quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer
    Abdulrezzak, U.
    Tutus, A.
    Kula, M.
    Kurt, Y.
    Kocaagaoglu, E.
    Sarikaya, Y.
    Isik, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S127 - S127
  • [33] Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study
    Hesselink, Esther N. Klein
    Brouwers, Adrienne H.
    de Jong, Johan R.
    van der Horst-Schrivers, Anouk N. A.
    Coppes, Rob P.
    Lefrandt, Joop D.
    Jager, Piet L.
    Vissink, Arjan
    Links, Thera P.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (11) : 1685 - 1691
  • [34] Testicular function after radioiodine therapy in patients with thyroid cancer
    Rosario, Pedro W. S.
    Barroso, Alvaro L.
    Rezende, Leonardo L.
    Padrao, Eduardo L.
    Borges, Michelle A. R.
    Guimaraes, Valeria C.
    Purisch, Saulo
    THYROID, 2006, 16 (07) : 667 - 670
  • [35] Ovarian function after radioiodine therapy in patients with thyroid cancer
    Rosário, PWS
    Fagundes, TA
    Fagundes, ASVB
    Barroso, AL
    Rezende, LL
    Padrao, EL
    Gulmaraes, VC
    Horta, AC
    Franco, M
    Purisch, S
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (06) : 331 - 333
  • [36] EVALUATION OF LOW-DOSE RADIOIODINE ABLATION THERAPY IN POSTSURGICAL THYROID-CANCER PATIENTS
    RAMANNA, L
    WAXMAN, AD
    BRACHMAN, MB
    TANASESCU, DE
    SENSEL, N
    BRAUNSTEIN, GD
    CLINICAL NUCLEAR MEDICINE, 1985, 10 (11) : 791 - 795
  • [37] Ultrasonographic Features of Salivary Glands after Radioiodine Therapy in Patients with Thyroid Cancer
    Tsur, Nir
    Avishai, Gal
    Alkan, Uri
    Hod, Roy
    Shpitzer, Thomas
    Bitton, Eden
    Gilat, Hanna
    LARYNGOSCOPE, 2023, 133 (05): : 1271 - 1275
  • [38] RADIOIODINE THERAPY OF METASTATIC CANCER OF THE THYROID-GLAND
    GOTTSCHILD, D
    NEUMANN, G
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1979, 34 (38): : 1843 - 1846
  • [39] A comparative study of the protective effect of vitamin C and amifostine to salivary gland function of differentiated thyroid cancer in 131I therapy
    Wang, Cong
    Fan, Ningfagn
    Liu, Jianzhong
    Jin Jianhua
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [40] Salivary gland dysfunction after radioiodine treatment in thyroid cancer patients with chronic renal failure
    Aktas, A.
    Kavak, K.
    Kocabas, B.
    Aras, M.
    Gencoglu, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S225 - S225
12345